Next 10 |
2024-04-18 12:10:02 ET More on Cisco, Goldman Sachs, etc. Cisco Won't Stay This Cheap For Long Goldman Sachs: A Profit Machine In A Turbulent Market? Goldman Sachs Q1 Earnings: A Solid Start To 2024, But Second Half Faces New Uncertainties Arista, Cisco remai...
2024-04-17 16:15:11 ET More on Boston Scientific Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Needha...
2024-04-15 09:00:04 ET Marie Thibault from BTIG issued a price target of $74.00 for BSX on 2024-04-15 07:35:00. The adjusted price target was set to $74.00. At the time of the announcement, BSX was trading at $68.07. The overall price target consensus is at $56.89 with h...
2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...
2024-04-10 14:56:07 ET More on Markets OKE and F: The only 5% dividend stocks within the S&P 500 that are beating the index YTD 10-year yield tops 4.5% after strong CPI report Chances of June rate cut narrow after hot CPI print CPI inflation stays hot in ...
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module PR Newswire MARLBOROUGH, Mass. , April 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiat...
2024-04-05 06:42:07 ET Summary Boston Scientific expects 8-10% sales growth in their 2024-2026 guidance, which already includes short-term upsides such as FARAPULSE’s recent FDA approval. The legal clash between Axonics and Medtronic may endanger Boston Scientific's ability...
2024-04-04 08:09:04 ET Boston Scientific’s ( NYSE: BSX ) planned merger with Axonics ( NASDAQ: AXNX ) is now expected to close in the second half of the year after the companies received a request from the U.S. Federal Trade Commission (FTC) for additional informa...
2024-04-03 09:00:03 ET John Eade from Argus Research issued a price target of $80.00 for BSX on 2024-04-03 07:37:00. The adjusted price target was set to $80.00. At the time of the announcement, BSX was trading at $67.45. The overall price target consensus is at $59.15 w...
2024-04-02 05:36:53 ET Summary Boston Scientific has rallied nearly 40% over the past year, driving its market value to a milestone of $100 billion for the first time. We preview BSX's upcoming Q1 earnings report set to be released on April 26th. While the company benefits fro...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has id...
BofA Securities upgraded Integer Holdings Corporation (NYSE:ITGR), citing the anticipated growth in pulsed field ablation (PFA) for ...
2024-04-15 09:00:04 ET Marie Thibault from BTIG issued a price target of $74.00 for BSX on 2024-04-15 07:35:00. The adjusted price target was set to $74.00. At the time of the announcement, BSX was trading at $68.07. The overall price target consensus is at $56.89 with h...